Case series on the use of aripiprazole for Tourette syndrome [3]

International Journal of Neuropsychopharmacology

Volumn 8, Issue 3, 2005, Pages 489-490

  Murphy, Tanya K ^a   Bengtson, Michael A ^a   Soto, Ohel ^a   Edge, Paula J ^a   Sajid, Muhammad W ^a   Shapira, Nathan ^a   Yang, Mark ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT;

ADOLESCENT; BODY MASS; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETTER; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CHILD; FEMALE; HUMANS; MALE; PIPERAZINES; QUINOLONES; RETROSPECTIVE STUDIES; TOURETTE SYNDROME;

EID: 22344448224     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145705005365     Document Type: Letter

References (3)

1. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry 46, 1012-1016.
2. Jordan S, Koprivica V, Dunn R, Tottori K, Kikuchi T, Altar CA (2004). In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function. European Journal of Pharmacology 483, 45-53.
3. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989). The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry 28, 566-573.